Fred Alger Management, LLC Pacira Bio Sciences, Inc. Transaction History

Fred Alger Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $950,820 - $1.25 Million	-26,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$36.47 - $42.17 $474,110 - $548,210	13,000 Added 100.0%	26,000 $990,000
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $1.95 Million - $2.47 Million	-47,279 Reduced 78.43%	13,000 $559,000
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $1.98 Million - $3.13 Million	60,279 New	60,279 $2.96 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.